Aleve data vs. Advil shows "trend" toward longer action, court says in rejecting AHP suit.

ALEVE CLINICAL DATA VS. ADVIL SHOWS "TREND" TOWARD LONGER ACTION, U.S. District Court Judge Nicholas Politan said Dec. 27 in deny-ing American Home Products' request for a preliminary injunction against Procter-Syntex. Politan stated that "it is patent" from evaluating three studies comparing the pain relief duration of naproxen sodium and ibuprofen with placebo over a 12-hour period that the "consistent trends of all three studies strongly suggest that naproxen sodium, that is, Aleve, has a longer duration and is more efficacious at the later hours (i.e., hours 8 through 12) than Advil."